SNUH-CD19-CAR-T

BIOLOGICAL2 trials

Sponsors

Seoul National University Hospital

Conditions

B-cell Acute Lymphoblastic LeukemiaCD19 CAR-T TherapyVery High Risk Acute Lymphoblastic Leukemia

Phase 1

Clinical Study of Hospital-manufactured CD19 CAR-T in Children and Adolescents With Acute Lymphoblastic Leukemia

RecruitingNCT05210907

Seoul National University HospitalB-cell Acute Lymphoblastic Leukemia

Start: 2022-02-15End: 2026-08-31Target: 5Updated: 2023-02-06

Phase 2

Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell Transplantation

RecruitingNCT06247501

Seoul National University HospitalCD19 CAR-T Therapy, Very High Risk Acute Lymphoblastic Leukemia

Start: 2024-01-19End: 2029-12-31Target: 50Updated: 2024-02-08